Filter
10
Filtered Results: 10
Text search:
K.
Manassis
Featured
Recommendations
1
New Publications
1
Language
Document type
No document type
7
Guidelines
2
Situation Updates
1
Countries / Regions
Haiti
1
Latin America and the Carribbean
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
1
Clinical Guidelines
1
Key Resources
1
Toolboxes
Mental Health
6
Rapid Response
1
HIV
1
COVID-19
1
Anxiety disorders
Chapter F.5
Trastornos de ansiedad
Capítulo F.5
Edición: Matías Irarrázaval & Andres Martin
Traductores: Fernanda Prieto-Tagle & Marcela Mezzatesta
In the current absence of vaccine for COVID-19, public health response target breaking the chain of infection by focusing on the mode of transmission. This paper summarizes current evidence-base around the transmission dynamics, pathogenic, and clinical features of COVID-19, to critically identify i...
Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4).
Patel V, Chisholm D, Dua T, et al., editors.
Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14.
Anxiety disorders
Chapter F.1
2018 edition
Dialogues Clin Neurosci. 2017 Jun; 19(2): 93–107.
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people ...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
